on
Tue, Nov 12, 2024
Learn more about how our CRISPR-derived A1AT cells can reproducibly recapitulate the disease phenotype in-a-dish, revealing increased polymeric alpha-1-antitrypsin formation and accumulation compared to their isogenic controls.
